News | April 05, 2007

MedicalCV’s Ablation Device Used in Closed-Chest Robotic Cardiac Procedure

April 6, 2007 — MedicalCV Inc., Minneapolis, MN, has announced that Allen R. Raczkowski, M.D., director of Robotic Cardiac Surgery at Banner Baywood Health Systems in Mesa, AZ, performed a closed-chest, robotic, lone cardiac ablation procedure on an arrested heart on March 30 using the ATRILAZE Surgical Ablation System.

"With a clinical history of unsuccessful medical treatment and interventional ablations, this patient was an ideal candidate for a minimally invasive operation. The versatility of the ATRILAZE wand allowed me to create the critical lesion sets with robotic assistance, providing the greatest chance of helping this patient," said Dr. Raczkowski, a leading pioneer in minimally invasive cardiac surgery. "I look forward to utilizing this and additional surgical ablation products from MedicalCV in the future."

The ATRILAZE Surgical Ablation System is a laser-based technology platform that provides cardiac tissue ablation in both open and endoscopic surgeries. The system is FDA cleared for ablation or coagulation of soft tissue, including cardiac tissue, but in the U.S. its use in treating cardiac arrhythmias is specifically excluded. To date, the product has been used in numerous institutions around the country including Baylor University Medical Center, Northwestern University Medical Center, Central DuPage Hospital, Baptist Medical Center in San Antonio, Texas, and Scottsdale Healthcare - Osborn in Arizona.

For more information visit www.medcvinc.com.

Related Content

CardioFocus Announces European CE Mark Approval Of HeartLight X3 System
News | Ablation Systems | April 16, 2019
CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System.
First Patient Treated With QDot Micro Ablation Catheter
News | Ablation Systems | February 04, 2019
Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study...
FDA Approves TactiCath Contact Force Ablation Catheter, Sensor Enabled
Technology | Ablation Systems | January 21, 2019
Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter,...
First Patient Treated in STELLAR Atrial Fibrillation IDE Study
News | Ablation Systems | November 30, 2018
Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and treated the first...
FDA Approves Biosense Webster's Tag-Index Guided Ablation Software
Technology | Ablation Systems | October 09, 2018
Biosense Webster Inc. recently received approval from the U.S. Food and Drug Administration (FDA) for its Visitag...
Medtronic Cryoballoon Improves Quality of Life, Reduces Systems of Persistent Atrial Fibrillation
News | Ablation Systems | August 28, 2018
Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life...
Thermedical Announces FDA IDE Approval for Clinical Study of Durablate Catheter
News | Ablation Systems | August 02, 2018
Thermedical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device...
Boston Scientific to Acquire Cryterion Medical Inc.
News | Ablation Systems | July 13, 2018
Boston Scientific Corp. recently announced a definitive agreement to acquire Cryterion Medical Inc., a privately-held...
Treating AFib With Ablation Reduces Mortality and Stroke
News | Ablation Systems | July 05, 2018
Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the...
LuxCath Showcases OmniView Light-Guided Ablation Catheter at HRS 2018
News | Ablation Systems | May 22, 2018
LuxCath LLC showcased the next generation of its proprietary OmniView light-guided catheter ablation system at the 2018...
Overlay Init